HEPION PHARMACEUTICALS, INC. Current Liabilities
HEPION PHARMACEUTICALS, INC. (HEPA) had Current Liabilities of $492.76 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $492.76K.
- 2026-03-31: Liabilities, Current $735.57K.
- 2025-12-31: Liabilities, Current $299.38K.
- 2025-09-30: Liabilities, Current $347.41K.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $492.76K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $735.57K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $299.38K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $347.41K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $592.85K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $935.92K 10-Q · filed 2025-05-19 | |
| 2024-12-31 | $3.14M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $2.72M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $975.63K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.57M 10-Q · filed 2024-05-21 | |
| 2023-12-31 | $5.29M 10-K · filed 2025-04-08 | |
| 2023-09-30 | $6.40M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $7.67M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $9.80M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $7.89M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $7.49M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $13.38M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $6.26M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $8.21M 10-K · filed 2023-04-10 | |
| 2021-09-30 | $7.08M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $7.10M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $2.87M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $4.66M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $3.96M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.60M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.54M 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $1.61M 10-K · filed 2021-03-31 | $1.25M 10-K · filed 2020-05-14 |
| 2019-09-30 | $1.51M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.80M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $3.46M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.85M 10-K · filed 2020-05-14 | |
| 2018-09-30 | $5.65M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $5.00M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.56M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.60M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $2.81M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $2.94M 10-KT · filed 2018-03-26 | |
| 2017-03-31 | $2.47M 10-Q · filed 2017-04-12 | |
| 2016-12-31 | $3.22M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $5.16M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.08M 10-KT · filed 2018-03-26 | |
| 2016-03-31 | $4.29M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $3.76M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $4.22M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.94M 10-K · filed 2016-09-28 | |
| 2015-03-31 | $1.62M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $360.95K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $464.70K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $458.74K 10-K · filed 2015-09-25 | |
| 2014-03-31 | $259.86K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $498.69K 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $398.56K 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $227.21K 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |